| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $33.76 | $43.13 | -21.73% | 84.39x | 7.86x | 9.01x | 3.87x | 0.29x | $46.73M | 2.72% | $450.12M | 8.86 | $1.73B | 59.50 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $313.41 | $82.68 | 279.07% | 131.13x | 42.01x | 11.06x | 52.67x | 1.58x | $465.38M | 1.13% | $789.18M | 6.02 | $42.88B | 67.90 | ||
| ADMA | ADMA BIOLOGICS INC | $15.15 | $11.30 | 34.11% | 24.44x | 16.41x | 7.08x | 7.56x | 0.67x | $27.82M | 0.77% | $477.32M | 2.00 | $3.59B | 18.16 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.98 | $19.62 | -49.14% | 7.13x | 17.63x | 5.18x | 3.79x | 0.29x | -$1.99M | -0.36% | $154.66M | 2.80 | $586.74M | 5.91 | ||
| CORT | CORCEPT THERAPEUTICS INC | $32.15 | $26.75 | 20.20% | 33.84x | 38.91x | 4.39x | 5.28x | 0.52x | $141.79M | 4.25% | $647.81M | 6.24 | $3.31B | 73.12 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.78 | $4.34 | 10.06% | 21.73x | 15.89x | 2.92x | 5.00x | 0.53x | $13.21M | 3.49% | $76.53M | 0.97 | $320.81M | 16.33 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.66 | $70.01 | -9.07% | 24.11x | 7.79x | 5.46x | 153.91x | 0.40x | $644.59M | 8.45% | $48.81M | 0.41 | $9.52B | 16.61 | ||
| XOMA | XOMA ROYALTY CORP | $26.38 | $15.13 | 74.35% | 32.57x | 83.91x | 6.80x | 3.71x | 0.86x | -$12.41M | -3.87% | $87.94M | 7.25 | $368.10M | 13.76 | ||
| ABEO | ABEONA THERAPEUTICS INC | $4.76 | $18.28 | -73.96% | 2.99x | -74.26x | 680.00x | 1.51x | 0.17x | -$82.36M | -31.89% | $171.23M | 3.16 | $198.84M | 2.21 | ||
| KRYS | KRYSTAL BIOTECH INC | $247.26 | $109.13 | 126.56% | 34.92x | 31.41x | 18.39x | 5.93x | 1.23x | $189.35M | 2.65% | $1.22B | 42.14 | $6.74B | 34.39 | ||
| RPRX | ROYALTY PHARMA PLC | $45.65 | $41.56 | 9.85% | 25.50x | 8.83x | 8.25x | 2.71x | 0.50x | $2.22B | 11.31% | $9.71B | 22.60 | $34.67B | 32.14 | ||
| VCEL | VERICEL CORP | $32.54 | $8.34 | 290.18% | 98.59x | 63.00x | 5.93x | 4.66x | 1.74x | $24.75M | 1.51% | $354.64M | 7.05 | $1.65B | 47.21 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.51 | $46.05 | 27.06% | 32.15x | 12.51x | 3.48x | 1.85x | 0.57x | $724.96M | 6.46% | $6.09B | 31.74 | $10.54B | 18.39 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $18.94 | $4.99 | 279.39% | 105.22x | -15.95x | 2.38x | 6.54x | 1.66x | $45.01M | 1.88% | $370.15M | 2.93 | $2.43B | 34.68 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $27.61 | $36.69 | -24.75% | 10.00x | 7.62x | 1.83x | 1.84x | 0.45x | $347.89M | 21.92% | $870.22M | 15.14 | $1.01B | 3.95 | ||
| TECH | BIO-TECHNE CORP | $50.85 | $15.54 | 227.17% | 97.79x | 25.08x | 6.52x | 3.96x | 1.40x | $223.02M | 2.81% | $2.01B | 12.90 | $8.13B | 35.92 | ||
| MNKD | MANNKIND CORP | $2.77 | $1.09 | 153.59% | 138.50x | 51.97x | 2.43x | -16.73x | 0.99x | $13.69M | 1.62% | -$51.02M | -0.17 | $1.38B | 26.14 | ||
| EXEL | EXELIXIS INC | $41.24 | $34.59 | 19.23% | 14.32x | 13.15x | 4.83x | 4.96x | 0.77x | $875.84M | 7.82% | $2.16B | 7.96 | $10.40B | 10.46 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.23 | $13.87 | 67.50% | 13.27x | 12.02x | 4.82x | 2.97x | 1.91x | $208.61M | 7.34% | $954.27M | 7.80 | $2.13B | 6.62 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $202.91 | $77.09 | 163.21% | 31.51x | 23.90x | 14.64x | 3.98x | 1.70x | $48.09M | 1.23% | $1.02B | 52.60 | $4.32B | 21.68 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $745.77 | $432.80 | 72.31% | 17.32x | 15.95x | 5.44x | 2.52x | 1.33x | $4.08B | 5.23% | $31.26B | 298.82 | $78.43B | 13.48 | ||
| VCYT | VERACYTE INC | $32.13 | $11.94 | 169.18% | 38.25x | 27.77x | 4.88x | 1.95x | 1.54x | $126.63M | 5.01% | $1.31B | 16.67 | $2.23B | 24.06 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $469.34 | $175.79 | 166.99% | 30.36x | 24.21x | 10.00x | 6.39x | 1.81x | $3.19B | 2.66% | $18.67B | 73.00 | $115.99B | 23.84 | ||
| CRMD | CORMEDIX INC | $6.45 | $12.48 | -48.31% | 2.87x | 4.74x | 1.49x | 1.26x | 17.43x | $172.79M | 37.19% | $405.31M | 5.63 | $513.95M | 3.07 | ||
| INCY | INCYTE CORP | $92.54 | $68.26 | 35.58% | 14.04x | 12.08x | 3.51x | 3.56x | 1.01x | $1.35B | 7.50% | $5.17B | 26.47 | $15.35B | 8.72 | ||
| UTHR | UNITED THERAPEUTICS CORP | $536.12 | $238.94 | 124.37% | 17.79x | 17.95x | 7.46x | 3.31x | 2.55x | $1.04B | 4.38% | $7.10B | 160.19 | $21.94B | 12.06 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.83 | $0.40 | 600.42% | 40.43x | 40.03x | 3.63x | 4.30x | 49.91x | -$11.69M | -5.19% | $52.91M | 0.67 | $222.12M | 25.04 | ||
| MDXG | MIMEDX GROUP INC | $4.38 | $1.88 | 132.72% | 13.27x | 37.89x | 1.55x | 2.54x | 21.62x | $72.97M | 11.28% | $256.55M | 1.74 | $502.57M | 6.32 |